Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadaaki Yamada

Showing results (71-80 of 228) with videos related to

Pageof 23
Sort By:
Cancer Science|October 15, 2013
Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancerLu Zhao, Kazuo Yasumoto, Atsuhiro Kawashima, et al.
International Journal of Clinical Oncology|July 6, 2010
Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinibTadaaki Yamada, Koushiro Ohtsubo, Kouji Izumi, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study)Kouji Izumi, Kazuyoshi Shigehara, Takahiro Nohara, et al.
Oncotarget|December 31, 2015
High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cellsShigeki Nanjo, Hiromichi Ebi, Sachiko Arai, et al.
Oncology Reports|January 1, 2014
Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesotheliomaMakio Moriya, Tadaaki Yamada, Masaya Tamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancerIvan S Donev, Wei Wang, Tadaaki Yamada, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2021
Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study)Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.
Oncology Research|October 8, 2009
A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient miceShinsaku Otsuka, Masaki Hanibuchi, Kenji Ikuta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2020
TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment SelectionAya Miyagawa-Hayashino, Satoru Okada, Naoko Takeda-Miyata, et al.
Respirology Case Reports|August 24, 2023
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case reportShota Takei, Akihiro Yoshimura, Chie Yamamoto, et al.
Pageof 23

Showing results (71-80 of 228) with videos related to

Sort By:
Pageof 23
Cancer Science|October 15, 2013
Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancerLu Zhao, Kazuo Yasumoto, Atsuhiro Kawashima, et al.
International Journal of Clinical Oncology|July 6, 2010
Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinibTadaaki Yamada, Koushiro Ohtsubo, Kouji Izumi, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study)Kouji Izumi, Kazuyoshi Shigehara, Takahiro Nohara, et al.
Oncotarget|December 31, 2015
High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cellsShigeki Nanjo, Hiromichi Ebi, Sachiko Arai, et al.
Oncology Reports|January 1, 2014
Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesotheliomaMakio Moriya, Tadaaki Yamada, Masaya Tamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancerIvan S Donev, Wei Wang, Tadaaki Yamada, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2021
Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study)Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.
Oncology Research|October 8, 2009
A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient miceShinsaku Otsuka, Masaki Hanibuchi, Kenji Ikuta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2020
TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment SelectionAya Miyagawa-Hayashino, Satoru Okada, Naoko Takeda-Miyata, et al.
Respirology Case Reports|August 24, 2023
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case reportShota Takei, Akihiro Yoshimura, Chie Yamamoto, et al.
Pageof 23